2025 annual financial data
Kura Oncology 2025 Operating margin
Direct answer
Operating margin was -449.94%.
Operating income was -303,631,000 USD and net income was -278,666,000 USD.
Operating cash flow was -64,058,000 USD.
Get free Kura Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,482,000 USD
- Operating income
- -303,631,000 USD
- Net income
- -278,666,000 USD
- Operating cash flow
- -64,058,000 USD